ArticleAngewandte Chemie (International ed. in English)2026
Bench-Stable Boryl Thianthrenium Dication Enables Aziridinyl Boronate Synthesis via Metal-Free Late-Stage Aziridination with Diverse Nitrogen Nucleophiles.
Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bench-Stable Boryl Thianthrenium Dication Enables Aziridinyl Boronate Synthesis via Metal-Free Late-Stage Aziridination with Diverse Nitrogen Nucleophiles.Angewandte Chemie (International ed. in English) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Organoboron compounds are indispensable in modern organic synthesis and biomedical research. This study describes the synthesis of bench-stable boryl thianthrenium dicationic compound via chemical or electrochemical thianthrenation of vinyl MIDA boronate. This unique boryl thianthrenium dication enables a transition-metal-free, chemo-, and diastereoselective synthesis of aziridinyl boronates, utilizing a broad range of nitrogen nucleophiles. The method demonstrates generality, practicality, and functional group tolerance, as evidenced by its application to diverse substrates, including the late-stage modification of drug molecules. Notably, the MIDA boryl group plays crucial roles in this approach including i) suppressing undesired deborylation, ii) promoting exclusive mono-adduct formation via a formal [4 + 2] cycloaddition pathway, iii) directing regioselective vinyl boryl thianthrenium formation via selective deprotonation, and iv) enabling diastereoselective aziridination. The strategic significance of this approach is further highlighted through electrochemical one-pot protocol, asymmetric synthesis using vinyl PIDA boronate, and diverse downstream transformations of aziridinyl boronates, offering new opportunities for synthetically challenging boron-containing drug-like scaffolds.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.